Argentina vs Belgium: Proportion of isolates with decreased susceptibility or resistance
Argentina
0
in 2020
Belgium
0.6
in 2020
Argentina rank
13th
Belgium rank
10th
Proportion of isolates with decreased susceptibility or resistance over time
- Argentina
- Belgium
How they compare
Belgium currently reports 0.6 against 0 in Argentina, a difference of 0.6.
Across all 10 years both countries report, Belgium has been ahead every year.
Argentina ranks 13th and Belgium ranks 10th of 52 countries.
Belgium has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Argentina | Belgium | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | — |
| 2010s | 0 | 0 | 0 | — |
| 2020s | 0 | 0.6 | 0.6 | Belgium |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Argentina or Belgium?
- Belgium, at 0.6 against 0 in Argentina as of 2020.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Argentina and Belgium?
- 0.6, with Belgium ahead.
- How many years of comparable data are there for Argentina and Belgium?
- 10 years are reported by both, from 2009 to 2020.
- How do Argentina and Belgium rank globally for proportion of isolates with decreased susceptibility or resistance?
- Argentina ranks 13th and Belgium ranks 10th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.